| Between 18 years et 85 years
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Thérapies Ciblées
Extract
A randomised, double-blind, placebo-controlled trial assessing the efficacy and safety of dutasteride (AVODART™) 0.5 mg in extending the time to PSA doubling in men with prostate cancer and biochemical failure (PSA increase) after radical therapy with curative intent (ARTS – AVODART after radical therapy for prostate cancer study).
Scientific Abstract
en cours d'intégration;